MedTrace Logo

Iron Supplementation Using Total Dose Infusion and Oral Routes for Treatment of Iron Deficiency Anemia in Pregnancy

NCT02086838 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2015-03-19

No results posted yet for this study

Summary

Evaluate the effect of iron supplementation using oral routes in comparison with total dose infusion of low molecular weight iron dextran in iron deficiency anemia during pregnancy.

Conditions

  • Treatment of Iron Deficiency Anemia in Pregnancy

Interventions

DRUG

Theragran Hematinic

DRUG

low molecular weight iron dextran

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Mohamed S. Sweed, MD · AinShams University

  • Hazem M. Sammour, Professor · AinShams University

  • Abdel-Latif G. El-Kholy, Ass. Prof. · AinShams University

  • Eman M. El-Garhi, M.B.B.Ch. · El Galaa Teaching Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02086838 on ClinicalTrials.gov